Noninvasive 40Hz light-and-sound brain stimulation aimed at Alzheimer’s changes with a female focus
Official title: Noninvasive Neurostimulation to Reduce Pathology in a Female Mouse Model of Alzheimer's Disease
Funded at Veterans Health Administration · NIH-11092943 · Data updated 2026-11-12
Seeing if gentle 40Hz light-and-sound stimulation can reduce Alzheimer’s-related brain changes that may be especially important for women.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Decatur, UNITED STATES) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2025 |
| NIH project number | 5IK2RX004544-03 |
| Project ID | NIH-11092943 on NIH RePORTER |
Who could benefit from this research
✓Could help
The most relevant human candidates for future trials would be women with early or prodromal Alzheimer's disease or older women at elevated risk for Alzheimer’s.
✕Less likely to help
People with advanced Alzheimer’s disease or other types of dementia are less likely to benefit from early-stage treatments aimed at preventing or reversing early pathology.
What this research studies
Researchers will use noninvasive 40Hz "gamma flicker" light and sound to stimulate brain activity in female mouse models of Alzheimer’s disease. They will measure effects on brain immune cells (microglia), inflammatory signals, and key brain chemicals such as dopamine, norepinephrine, and BDNF that support memory. The team will target early, prodromal stages before neuron loss to see whether pathology and memory problems can be reduced. Results in mice would help decide if similar, women-focused human trials should be pursued.
Why it matters
Potential benefit: If successful, this approach could point to a noninvasive therapy to reduce Alzheimer’s pathology and help preserve memory, particularly for women.
How similar studies have gone: Related 40Hz "gamma" stimulation reduced amyloid and engaged microglia in prior mouse studies and has been explored in small early human pilot projects, but evidence in people is still preliminary.
Where this research is happening
-
Veterans Health Administration
Decatur, United States Active
Researchers
- Principal investigator: Prichard, Ashley — Veterans Health Administration
- Study coordinator: Prichard, Ashley
Related research
Other NIH-funded projects on the same topics.
-
How X chromosome genes may increase Alzheimer's risk in women
Researchers are looking at genes on the X chromosome to learn how they might raise tau and Alzheimer's risk specifically in women.
-
Noninvasive gamma flicker to help Alzheimer’s disease pathways in a female-model study
A research project tests a noninvasive light/sound therapy to potentially slow Alzheimer’s-related brain changes in a female mouse model that mimics human disease.
-
Using noninvasive brain stimulation to improve Alzheimer's disease in female mice
This study is looking at how a gentle light and sound treatment might help improve memory and learning in female mice with Alzheimer's, and it aims to find better ways to treat the disease by focusing on how it affects females differently.
-
Investigating how sex genes affect women's risk of Alzheimer's disease
This study is looking into why women might be more at risk for Alzheimer's disease than men, focusing on how certain genes on the X chromosome and hormones could play a role, with the goal of finding new ways to prevent and treat Alzheimer's in women.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.